These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 3501295

  • 1. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
    Stief TW, Radtke KP, Heimburger N.
    Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1427-33. PubMed ID: 3501295
    [Abstract] [Full Text] [Related]

  • 2. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
    Radtke KP, Stief TW, Heimburger N.
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
    [Abstract] [Full Text] [Related]

  • 3. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
    Radtke KP, Wenz KH, Heimburger N.
    Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA, Nielsen LS, Kristensen P, Grøndahl-Hansen J, Skriver L, Danø K.
    J Biol Chem; 1986 Jun 15; 261(17):7644-51. PubMed ID: 3086313
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I.
    Thromb Haemost; 1978 Jun 30; 39(3):616-23. PubMed ID: 705690
    [Abstract] [Full Text] [Related]

  • 6. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC, Reich E.
    J Biol Chem; 1987 Mar 15; 262(8):3646-53. PubMed ID: 3102492
    [Abstract] [Full Text] [Related]

  • 7. Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
    Okada K, Fukao H, Tanaka H, Ueshima S, Matsuo O.
    Thromb Res Suppl; 1990 Mar 15; 10():27-43. PubMed ID: 2156352
    [Abstract] [Full Text] [Related]

  • 8. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H, Stephens RW, Nakagawa T, McNicol D.
    J Biochem; 1988 Dec 15; 104(6):960-7. PubMed ID: 3149640
    [Abstract] [Full Text] [Related]

  • 9. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.
    Heeb MJ, España F, Geiger M, Collen D, Stump DC, Griffin JH.
    J Biol Chem; 1987 Nov 25; 262(33):15813-6. PubMed ID: 2824468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S, Philips M, Selmer J, Lecander I, Astedt B.
    Eur J Biochem; 1988 Jul 15; 175(1):33-9. PubMed ID: 3136015
    [Abstract] [Full Text] [Related]

  • 12. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
    Stump DC, Thienpont M, Collen D.
    J Biol Chem; 1986 Sep 25; 261(27):12759-66. PubMed ID: 3091604
    [Abstract] [Full Text] [Related]

  • 13. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM, Loskutoff DJ.
    Arch Biochem Biophys; 1988 Apr 25; 262(1):199-210. PubMed ID: 3128176
    [Abstract] [Full Text] [Related]

  • 14. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ, De Mol M, Alessi MC, Baudner S, Pâques EP, Preissner KT, Müller-Berghaus G, Collen D.
    J Biol Chem; 1988 Oct 25; 263(30):15454-61. PubMed ID: 2459123
    [Abstract] [Full Text] [Related]

  • 15. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M, Juul AG, Thorsen S.
    Biochim Biophys Acta; 1984 Nov 06; 802(1):99-110. PubMed ID: 6435688
    [Abstract] [Full Text] [Related]

  • 16. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA, Christensen TH, Huang JY, Nielsen LS, Wilson EL, Danø K.
    Mol Cell Endocrinol; 1986 May 06; 45(2-3):137-47. PubMed ID: 3011558
    [Abstract] [Full Text] [Related]

  • 17. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
    Fay WP, Owen WG.
    Biochemistry; 1989 Jul 11; 28(14):5773-8. PubMed ID: 2505842
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
    Reilly TM, Seetharam R, Duke JL, Davis GL, Pierce SK, Walton HL, Kingsley D, Sisk WP.
    J Biol Chem; 1990 Jun 05; 265(16):9570-4. PubMed ID: 2188980
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 05; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 20. Diversity of human plasma protein C inhibitor.
    Saito A.
    Thromb Res; 2012 Oct 05; 130(4):661-6. PubMed ID: 22206708
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.